Bupivacaine

   
Google
 
Web NewDrugInformation.com

Bupivacaine


Drug - Bupivacaine
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; SPINAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Bupivacaine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 0.75%
The potency of the active ingredient(s), Bupivacaine Hydrochloride. May repeat for multiple part products.

Applicant - HOSPIRA
The firm name holding legal responsibility for Bupivacaine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 071810
The FDA assigned number to Bupivacaine. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Bupivacaine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 11, 1987
The date Bupivacaine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Bupivacaine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Bupivacaine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Hospira Inc
The full name of the firm holding legal responsibility for the new application of Bupivacaine.

Bupivacaine